Histone deacetylase inhibitors: a novel class of anti-cancer agents on its way to the market.

Q1 Pharmacology, Toxicology and Pharmaceutics

Progress in medicinal chemistry Pub Date : 2008-01-01 DOI:10.1016/S0079-6468(07)00005-7

Matthias Körner, Ulrich Tibes

引用次数: 12

查看原文本刊更多论文

组蛋白去乙酰化酶抑制剂:一类即将上市的新型抗癌药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Progress in medicinal chemistry Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

15.60

自引率

0.00%

发文量

期刊介绍： This series has a long established reputation for excellent coverage of almost every facet of Medicinal Chemistry and is one of the most respected and instructive sources of information on the subject. The latest volume certifies to the continuing success of a unique series reflecting current progress in a broadly developing field of science.